Page last updated: 2024-11-05

benzyl acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Benzyl acetate is a colorless liquid with a sweet, floral aroma commonly found in perfumes and fragrances. It is synthesized through the esterification reaction of benzyl alcohol with acetic acid, catalyzed by an acid like sulfuric acid. Benzyl acetate is known for its antimicrobial properties, particularly against bacteria and fungi. Its pleasant odor makes it a popular ingredient in perfumes and cosmetics, and it is also used as a flavoring agent in food and beverages. It is studied for its potential applications in the food industry as a preservative and flavor enhancer. Further research is being conducted to explore its antimicrobial potential for therapeutic uses.'

benzyl acetate : The acetate ester of benzyl alcohol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8785
CHEMBL ID1233714
CHEBI ID52051
SCHEMBL ID43745
MeSH IDM0134479

Synonyms (86)

Synonym
LS-13613
CHEMBL1233714
e1501 ,
AKOS015841099
nci-c06508
wln: 1vo1r
nsc-4550
benzyl ethanoate
acetic acid, benzyl ester
nsc4550
140-11-4
acetic acid, phenylmethyl ester
.alpha.-acetoxytoluene
benzyl acetate
acetato de bencilo
phenylmethyl acetate
phenylmethyl ethanoate
alpha-acetoxytoluene
acetic acid phenylmethyl ester
nsc 4550
einecs 205-399-7
hsdb 2851
caswell no. 081ea
benzyl acetate (natural)
fema no. 2135
benzylester kyseliny octove [czech]
ai3-01996
ccris 1423
(acetoxymethyl)benzene
acetic acid benzyl ester
inchi=1/c9h10o2/c1-8(10)11-7-9-5-3-2-4-6-9/h2-6h,7h2,1h
NCGC00090779-01
benzyl acetate, natural, >=99%, fcc, fg
benzyl acetate, >=99%
benzyl acetate, >=99%, fcc, fg
NCGC00090779-02
benzyl acetate + glycine combination
NCHEM.167-COMP5 ,
CHEBI:52051 ,
j0z ,
A0022
NCGC00090779-03
dtxsid0020151 ,
dtxcid40151
cas-140-11-4
NCGC00256379-01
tox21_302841
tox21_201826
NCGC00259375-01
STL283809
fema 2135
0ecg3v79zj ,
ec 205-399-7
unii-0ecg3v79zj
benzylester kyseliny octove
FT-0621741
benzylacetate
S5576
benzyl acetate [hsdb]
benzyl acetate [vandf]
benzyl acetate [iarc]
benzyl acetate [fcc]
benzyl acetate [mi]
benzyl acetate [fhfi]
benzyl acetate [inci]
SCHEMBL43745
W-200649
plastolin i
benzyl ester of acetic acid
mfcd00008712
benzyl acetate, analytical standard
benzyl acetate, selectophore(tm), >=99.5%
benzyl acetate, primary pharmaceutical reference standard
J-007357
acetic acid,phenylmethyl ester
HY-N7124
Q424223
AMY3828
CCG-266204
CS-W018145
acetic acid-benzyl ester
?benzyl acetate
benzyl-23456-d5 acetate
EN300-1267317
Z19628364
benzyl acetate (iarc)

Research Excerpts

Overview

Benzyl acetate is a member of the fragrance structural group aryl alkyl alcohol simple acid esters (AAASAE)

ExcerptReferenceRelevance
"Benzyl acetate is a member of the fragrance structural group aryl alkyl alcohol simple acid esters (AAASAE)."( Fragrance material review on benzyl acetate.
Api, AM; Letizia, CS; McGinty, D; Vitale, D, 2012
)
1.39

Dosage Studied

Gavage versus dosed feed administration studied in male F344 rats and B6C3F1 mice. Mean body weights of control and dosed rats and mice were not affected adversely by benzyl acetate.

ExcerptRelevanceReference
" In both young and old rats and mice, hippuric acid (HA) was the major urinary metabolite after oral dosing of BA."( Age-related changes in the disposition of benzyl acetate. A model compound for glycine conjugation.
Birnbaum, LS; Diliberto, JJ; McMahon, TF,
)
0.4
" Male Fischer 344 rats were dosed by gavage with [methylene-14C]benzyl acetate (500 mg/kg) alone or together with pyrazole (200 mg/kg), pentachlorophenol (10 mg/kg) or both pentachlorophenol (10 mg/kg) and pyrazole (200 mg/kg), given in each case ip."( Studies on benzyl acetate. II. Use of specific metabolic inhibitors to define the pathway leading to the formation of benzylmercapturic acid in the rat.
Caldwell, J; Chidgey, MA; Kennedy, JF, 1986
)
0.9
" Mean body weights of control and dosed rats and mice were not affected adversely by benzyl acetate."( Benzyl acetate carcinogenicity, metabolism, and disposition in Fischer 344 rats and B6C3F1 mice.
Abdo, KM; Boorman, GA; Burka, LT; Eustis, SL; Haseman, JK; Huff, JE; Matthews, HB; Prejean, JD; Thompson, RB, 1985
)
1.94
"Effects of gavage versus dosed feed administration on the toxicokinetics of benzyl acetate were studied in male F344 rats and B6C3F1 mice."( Effects of gavage versus dosed feed administration on the toxicokinetics of benzyl acetate in rats and mice.
Abdo, K; Bugge, C; Clark, J; Espinosa, O; Garcia, D; Goehl, TJ; Yuan, JH, 1995
)
0.75
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
acetate esterAny carboxylic ester where the carboxylic acid component is acetic acid.
benzyl ester
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
volatile benzenoid biosynthesis I (ester formation)119

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency10.26260.000714.592883.7951AID1259392
AR proteinHomo sapiens (human)Potency6.10360.000221.22318,912.5098AID1259243; AID1259247
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency19.95260.011212.4002100.0000AID1030
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency17.60810.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency69.63720.001530.607315,848.9004AID1224841
estrogen nuclear receptor alphaHomo sapiens (human)Potency13.69060.000229.305416,493.5996AID1259383; AID588513; AID743069; AID743075
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency0.00070.001024.504861.6448AID588535
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency31.62280.010039.53711,122.0200AID588547
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency30.63790.000627.21521,122.0200AID651741
Inositol monophosphatase 1Rattus norvegicus (Norway rat)Potency6.30961.000010.475628.1838AID1457
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (23.08)18.7374
1990's11 (21.15)18.2507
2000's10 (19.23)29.6817
2010's14 (26.92)24.3611
2020's5 (9.62)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 67.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index67.35 (24.57)
Research Supply Index4.03 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index111.87 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (67.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (7.27%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other51 (92.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]